Taro Pharmaceutical Industries Ltd.Yakum, Israel (Pink Sheets: TAROF)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Taro Financial Statements

Taro Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Taro Income Statement

  2008* 2005 2004
Revenue ($ mil.) 341.9 297.7 284.1
Gross Profit ($ mil.) 187.2 169.1 164.7
Operating Income ($ mil.) 78.0 15.2 (0.5)
Total Net Income ($ mil.) 51.4 5.7 11.1
Diluted EPS (Net Income) 1.27 0.19 0.37
  • * Irregular reporting interval
More Taro financial information

Taro Quarterly Statements

  Quarter Ending Jun 09 Quarter Ending Mar 09 Quarter Ending Dec 08
Revenue ($ mil.) 96.8 84.9 85.3
Gross Profit ($ mil.) 57.9 46.5 46.3
Operating Income ($ mil.) -- 16.7 (13,525.2)
Total Net Income ($ mil.) 12.5 11.1 18.3
Diluted EPS (Net Income) 0.31 0.27 0.45
More Taro financial information

Taro Financial Ratios

  Company Industry
Median
Market
Median1
Price/Sales Ratio 1.06 16.45 7.01
Price/Earnings Ratio 6.93 384.62 25.51
Price/Book Ratio -- 3.53 6.74
Price/Cash Flow Ratio 5.85 80.00 43.48
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Taro Financial Ratios

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy